Back to Search
Start Over
An initial randomized controlled trial of behavioral activation for treatment of concurrent crystal methamphetamine dependence and sexual risk for HIV acquisition among men who have sex with men.
- Source :
-
AIDS Care . Sep2019, Vol. 31 Issue 9, p1083-1095. 13p. 1 Diagram, 4 Charts. - Publication Year :
- 2019
-
Abstract
- Men who have sex with men (MSM) continue to be the largest risk group for HIV infections in the U.S., where crystal methamphetamine abuse heightens risk for HIV infection through greater engagement in condomless anal sex (CAS). Existing treatments lack attention to replacement activities or the role of depressed mood. Behavioral activation (BA) is an evidence-based approach for depression that involves identifying and participating in pleasurable, goal-directed activities. We hypothesize, for MSM abusing crystal methamphetamine, re-learning how to engage in non-drug-using aspects of life would facilitate their ability to benefit from sexual risk reduction (SRR) counseling. Project IMPACT was a pilot randomized-controlled-trial. Forty-six MSM at sexual risk of acquiring HIV who met DSM-IV criteria for crystal methamphetamine dependence were enrolled. Of those MSM, 41 were randomized: 21 were assigned to the intervention, two sessions of SRR, ten sessions of BA with SRR, and one session of relapse prevention; 20 participants were assigned to a control condition (two sessions of SRR). At the acute post-intervention visit, intervention participants reported an average of 3.2 CAS acts with men who were HIV-infected or whose status they did not know, compared to 4.5 among control participants (β = −0.36; 95% CI: −0.69, −0.02; p = 0.035). At the 6-month post-intervention visit, intervention participants reported 1.1 CAS acts with men who were HIV-infected or whose status they did not know compared to 2.8 among control participants (β = −0.95; 95% CI: −1.44, −0.46; p < 0.0001). Similarly, intervention participants reported 1.0 CAS acts under the influence of crystal methamphetamine with men who were HIV-infected or whose status they did not know compared to 2.5 among control participants (β = −0.87; 95% CI: −1.38, −0.36; p = 0.0005). Lastly, intervention participants reported more continuous days abstaining from crystal methamphetamine compared to control (50.1 vs. 39.0, respectively) (β = 0.25; 95% CI: 0.16, 0.34; p < 0.0001). Findings are encouraging, provide evidence of feasibility and acceptability, and demonstrate initial efficacy for reducing sexual risk for HIV and crystal methamphetamine use. [ABSTRACT FROM AUTHOR]
- Subjects :
- *HIV infection risk factors
*TREATMENT of drug addiction
*DIAGNOSIS of drug addictions
*RISK management in business
*COGNITIVE therapy
*CONFIDENCE intervals
*HIV-positive persons
*MEDICAL appointments
*CLASSIFICATION of mental disorders
*METHAMPHETAMINE
*SEX counseling
*PILOT projects
*ANAL sex
*UNSAFE sex
*RANDOMIZED controlled trials
*MEN who have sex with men
DISEASE relapse prevention
Subjects
Details
- Language :
- English
- ISSN :
- 09540121
- Volume :
- 31
- Issue :
- 9
- Database :
- Academic Search Index
- Journal :
- AIDS Care
- Publication Type :
- Academic Journal
- Accession number :
- 137434297
- Full Text :
- https://doi.org/10.1080/09540121.2019.1595518